Japan Irritable Bowel Syndrome Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Irritable Bowel Syndrome market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Irritable Bowel Syndrome market. Detailed analysis of key players, along with key growth strategies adopted by Irritable Bowel Syndrome industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Synergy Pharma

    • Takeda

    • AstraZeneca

    • Bausch Health Companies Inc

    • Ironwood Pharmaceuticals

    • Sebela Pharmaceuticals

    • Sucampo

    • Allergan.

    • Astellas


    By Type:

    • Diarrhea-predominant (IBS-D)

    • Constipation-predominant (IBS-C)

    • Mixed-presentation (IBS-M)


    By End-User:

    • Women

    • Men


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Irritable Bowel Syndrome Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Irritable Bowel Syndrome Market Size and Growth Rate of Diarrhea-predominant (IBS-D) from 2014 to 2026

      • 1.3.2 Japan Irritable Bowel Syndrome Market Size and Growth Rate of Constipation-predominant (IBS-C) from 2014 to 2026

      • 1.3.3 Japan Irritable Bowel Syndrome Market Size and Growth Rate of Mixed-presentation (IBS-M) from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Irritable Bowel Syndrome Market Size and Growth Rate of Women from 2014 to 2026

      • 1.4.2 Japan Irritable Bowel Syndrome Market Size and Growth Rate of Men from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Irritable Bowel Syndrome Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Irritable Bowel Syndrome by Major Types

      • 3.4.1 Market Size and Growth Rate of Diarrhea-predominant (IBS-D)

      • 3.4.2 Market Size and Growth Rate of Constipation-predominant (IBS-C)

      • 3.4.3 Market Size and Growth Rate of Mixed-presentation (IBS-M)


    4 Segmentation of Irritable Bowel Syndrome Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Irritable Bowel Syndrome by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Irritable Bowel Syndrome in Women

      • 4.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome in Men


    5 Market Analysis by Regions

    • 5.1 Japan Irritable Bowel Syndrome Production Analysis by Regions

    • 5.2 Japan Irritable Bowel Syndrome Consumption Analysis by Regions


    6 Hokkaido Irritable Bowel Syndrome Landscape Analysis

    • 6.1 Hokkaido Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 6.2 Hokkaido Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    7 Tohoku Irritable Bowel Syndrome Landscape Analysis

    • 7.1 Tohoku Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 7.2 Tohoku Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    8 Kanto Irritable Bowel Syndrome Landscape Analysis

    • 8.1 Kanto Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 8.2 Kanto Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    9 Chubu Irritable Bowel Syndrome Landscape Analysis

    • 9.1 Chubu Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 9.2 Chubu Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    10 Kinki Irritable Bowel Syndrome Landscape Analysis

    • 10.1 Kinki Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 10.2 Kinki Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    11 Chugoku Irritable Bowel Syndrome Landscape Analysis

    • 11.1 Chugoku Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 11.2 Chugoku Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    12 Shikoku Irritable Bowel Syndrome Landscape Analysis

    • 12.1 Shikoku Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 12.2 Shikoku Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    13 Kyushu Irritable Bowel Syndrome Landscape Analysis

    • 13.1 Kyushu Irritable Bowel Syndrome Landscape Analysis by Major Types

    • 13.2 Kyushu Irritable Bowel Syndrome Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Synergy Pharma

      • 14.1.1 Synergy Pharma Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Takeda

      • 14.2.1 Takeda Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 AstraZeneca

      • 14.3.1 AstraZeneca Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Bausch Health Companies Inc

      • 14.4.1 Bausch Health Companies Inc Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Ironwood Pharmaceuticals

      • 14.5.1 Ironwood Pharmaceuticals Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Sebela Pharmaceuticals

      • 14.6.1 Sebela Pharmaceuticals Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Sucampo

      • 14.7.1 Sucampo Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Allergan.

      • 14.8.1 Allergan. Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Astellas

      • 14.9.1 Astellas Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 106 Figures and 171 Tables)

     

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Diarrhea-predominant (IBS-D) from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Constipation-predominant (IBS-C) from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Mixed-presentation (IBS-M) from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Women from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Men from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Irritable Bowel Syndrome Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Irritable Bowel Syndrome Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Irritable Bowel Syndrome

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Irritable Bowel Syndrome by Different Types from 2014 to 2026

    • Table Consumption Share of Irritable Bowel Syndrome by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diarrhea-predominant (IBS-D)

    • Figure Market Size and Growth Rate of Constipation-predominant (IBS-C)

    • Figure Market Size and Growth Rate of Mixed-presentation (IBS-M)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Irritable Bowel Syndrome by Different End-Users from 2014 to 2026

    • Table Consumption Share of Irritable Bowel Syndrome by Different End-Users from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Women from 2014 to 2026

    • Figure Japan Irritable Bowel Syndrome Market Size and Growth Rate of Men from 2014 to 2026

    • Table Japan Irritable Bowel Syndrome Production by Regions

    • Table Japan Irritable Bowel Syndrome Production Share by Regions

    • Figure Japan Irritable Bowel Syndrome Production Share by Regions in 2014

    • Figure Japan Irritable Bowel Syndrome Production Share by Regions in 2018

    • Figure Japan Irritable Bowel Syndrome Production Share by Regions in 2026

    • Table Japan Irritable Bowel Syndrome Consumption by Regions

    • Table Japan Irritable Bowel Syndrome Consumption Share by Regions

    • Figure Japan Irritable Bowel Syndrome Consumption Share by Regions in 2014

    • Figure Japan Irritable Bowel Syndrome Consumption Share by Regions in 2018

    • Figure Japan Irritable Bowel Syndrome Consumption Share by Regions in 2026

    • Table Hokkaido Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Hokkaido Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Hokkaido Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Hokkaido Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Tohoku Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Tohoku Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Tohoku Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Tohoku Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Tohoku Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Tohoku Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Tohoku Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Tohoku Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Kanto Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Kanto Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Kanto Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Kanto Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Kanto Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Kanto Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Kanto Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Kanto Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Kanto Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Chubu Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Chubu Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Chubu Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Chubu Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Chubu Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Chubu Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Chubu Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Chubu Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Chubu Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Kinki Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Kinki Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Kinki Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Kinki Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Kinki Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Kinki Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Kinki Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Kinki Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Kinki Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Chugoku Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Chugoku Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Chugoku Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Chugoku Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Chugoku Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Chugoku Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Chugoku Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Chugoku Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Shikoku Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Shikoku Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Shikoku Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Shikoku Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Shikoku Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Shikoku Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Shikoku Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Shikoku Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Kyushu Irritable Bowel Syndrome Consumption by Types from 2014 to 2026

    • Table Kyushu Irritable Bowel Syndrome Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Irritable Bowel Syndrome Consumption Share by Types in 2014

    • Figure Kyushu Irritable Bowel Syndrome Consumption Share by Types in 2018

    • Figure Kyushu Irritable Bowel Syndrome Consumption Share by Types in 2026

    • Table Kyushu Irritable Bowel Syndrome Consumption by End-Users from 2014 to 2026

    • Table Kyushu Irritable Bowel Syndrome Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Irritable Bowel Syndrome Consumption Share by End-Users in 2014

    • Figure Kyushu Irritable Bowel Syndrome Consumption Share by End-Users in 2018

    • Figure Kyushu Irritable Bowel Syndrome Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Synergy Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synergy Pharma

    • Figure Sales and Growth Rate Analysis of Synergy Pharma

    • Figure Revenue and Market Share Analysis of Synergy Pharma

    • Table Product and Service Introduction of Synergy Pharma

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Bausch Health Companies Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch Health Companies Inc

    • Figure Sales and Growth Rate Analysis of Bausch Health Companies Inc

    • Figure Revenue and Market Share Analysis of Bausch Health Companies Inc

    • Table Product and Service Introduction of Bausch Health Companies Inc

    • Table Company Profile and Development Status of Ironwood Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals

    • Table Product and Service Introduction of Ironwood Pharmaceuticals

    • Table Company Profile and Development Status of Sebela Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sebela Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sebela Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sebela Pharmaceuticals

    • Table Product and Service Introduction of Sebela Pharmaceuticals

    • Table Company Profile and Development Status of Sucampo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo

    • Figure Sales and Growth Rate Analysis of Sucampo

    • Figure Revenue and Market Share Analysis of Sucampo

    • Table Product and Service Introduction of Sucampo

    • Table Company Profile and Development Status of Allergan.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan.

    • Figure Sales and Growth Rate Analysis of Allergan.

    • Figure Revenue and Market Share Analysis of Allergan.

    • Table Product and Service Introduction of Allergan.

    • Table Company Profile and Development Status of Astellas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas

    • Figure Sales and Growth Rate Analysis of Astellas

    • Figure Revenue and Market Share Analysis of Astellas

    • Table Product and Service Introduction of Astellas

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.